Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sexual function in men with lower urinary tract symptoms].

T Ichikawa1, A Takao, Y Nakayama

  • 1Department of Urology, Hiroshima City Hospital.

Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|June 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Color-matching Ability of a Structural Colored Resin Composite.

Operative dentistry·2021
Same author

Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma.

Molecular cancer·2017
Same author

Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.

The Journal of pathology·2008
Same author

Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.

Journal of clinical pathology·2007
Same author

Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.

The Journal of pathology·2007
Same author

Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat.

Xenobiotica; the fate of foreign compounds in biological systems·2002

Men with lower urinary tract symptoms (LUTS) frequently experience erectile dysfunction. Increased LUTS severity correlates with poorer sexual function, impacting quality of life and necessitating integrated treatment approaches.

Area of Science:

  • Urology
  • Andrology
  • Men's Health

Context:

  • Lower urinary tract symptoms (LUTS) affect a significant portion of the aging male population.
  • Erectile dysfunction (ED) is a common comorbidity impacting men's quality of life.
  • Current treatment strategies for LUTS may not fully address associated sexual dysfunction.

Purpose:

  • To quantitatively and qualitatively evaluate the degree of erectile dysfunction (ED) in men presenting with lower urinary tract symptoms (LUTS).
  • To explore the correlation between LUTS severity, age, and various domains of sexual function.

Summary:

  • A study of 208 men with LUTS revealed high rates of sexual dysfunction, with 46.2% reporting poor erection quality and 20.7% citing erection issues as a significant problem.
  • Significant correlations were found between patient age and sexual function scores, as well as between the International Prostate Symptom Score (I-PSS) and sexual function.

Related Experiment Videos

  • Findings suggest that greater LUTS severity is associated with poorer sexual function, with approximately 20% of men with LUTS reporting bothersome sexual symptoms.

    • Impact:

    • Highlights the substantial prevalence of erectile dysfunction in men with LUTS.
    • Emphasizes the need for integrated management strategies that address both urinary and sexual symptoms in this population.
    • Informs clinical practice regarding the importance of assessing sexual health in men undergoing treatment for LUTS.